Literature DB >> 21791526

An emerging role for TOR signaling in mammalian tissue and stem cell physiology.

Ryan C Russell1, Chong Fang, Kun-Liang Guan.   

Abstract

The mammalian target of rapamycin (mTOR) is a kinase that responds to a myriad of signals, ranging from nutrient availability and energy status, to cellular stressors, oxygen sensors and growth factors. The finely tuned response of mTOR to these stimuli results in alterations to cell metabolism and cell growth. Recent studies of conditional knockouts of mTOR pathway components in mice have affirmed the role of mTOR signaling in energy balance, both at the cell and whole organism levels. Such studies have also highlighted a role for mTOR in stem cell homeostasis and lifespan determination. Here, we discuss the molecular mechanisms of TOR signaling and review recent in vitro and in vivo studies of mTOR tissue-specific activities in mammals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791526      PMCID: PMC3143559          DOI: 10.1242/dev.058230

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  155 in total

1.  GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Robert R Latek; Kalyani V P Guntur; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

2.  Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.

Authors:  Robbie Loewith; Estela Jacinto; Stephan Wullschleger; Anja Lorberg; José L Crespo; Débora Bonenfant; Wolfgang Oppliger; Paul Jenoe; Michael N Hall
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

3.  Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling.

Authors:  Thomas Radimerski; Jacques Montagne; Maja Hemmings-Mieszczak; George Thomas
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

4.  Activation of mTORC2 by association with the ribosome.

Authors:  Vittoria Zinzalla; Daniele Stracka; Wolfgang Oppliger; Michael N Hall
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

5.  Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM).

Authors:  Elena A Goncharova; Dmitry A Goncharov; Andrew Eszterhas; Deborah S Hunter; Marilyn K Glassberg; Raymond S Yeung; Cheryl L Walker; Daniel Noonan; David J Kwiatkowski; Margaret M Chou; Reynold A Panettieri; Vera P Krymskaya
Journal:  J Biol Chem       Date:  2002-06-03       Impact factor: 5.157

6.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

7.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

8.  Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling.

Authors:  Xinsheng Gao; Yong Zhang; Peter Arrazola; Okio Hino; Toshiyuki Kobayashi; Raymond S Yeung; Binggeng Ru; Duojia Pan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

9.  Identification of a proline-rich Akt substrate as a 14-3-3 binding partner.

Authors:  Kristina S Kovacina; Grace Y Park; Sun Sik Bae; Andrew W Guzzetta; Erik Schaefer; Morris J Birnbaum; Richard A Roth
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

10.  Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila.

Authors:  Rita Sousa-Nunes; Lih Ling Yee; Alex P Gould
Journal:  Nature       Date:  2011-02-23       Impact factor: 49.962

View more
  58 in total

1.  S6K links cell fate, cell cycle and nutrient response in C. elegans germline stem/progenitor cells.

Authors:  Dorota Z Korta; Simon Tuck; E Jane Albert Hubbard
Journal:  Development       Date:  2012-01-25       Impact factor: 6.868

Review 2.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

3.  Arrest of myelination and reduced axon growth when Schwann cells lack mTOR.

Authors:  Diane L Sherman; Michiel Krols; Lai-Man N Wu; Matthew Grove; Klaus-Armin Nave; Yann-Gaël Gangloff; Peter J Brophy
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

Review 4.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

Review 5.  mTOR signaling in epilepsy: insights from malformations of cortical development.

Authors:  Peter B Crino
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

6.  Translation regulation in skin cancer from a tRNA point of view.

Authors:  Katerina Grafanaki; Dimitrios Anastasakis; George Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; Constantinos Stathopoulos
Journal:  Epigenomics       Date:  2018-12-19       Impact factor: 4.778

Review 7.  Control of cell growth: Rag GTPases in activation of TORC1.

Authors:  Huirong Yang; Rui Gong; Yanhui Xu
Journal:  Cell Mol Life Sci       Date:  2012-12-16       Impact factor: 9.261

8.  Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model.

Authors:  Dong Li; Hong Yang; Hong Nan; Peng Liu; Sulei Pang; Qian Zhao; Rotem Karni; Mark P Kamps; Yuanfu Xu; Jiaxi Zhou; Therese Wiedmer; Peter J Sims; Fei Wang
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

9.  Tricornered/NDR kinase signaling mediates PINK1-directed mitochondrial quality control and tissue maintenance.

Authors:  Zhihao Wu; Tomoyo Sawada; Kahori Shiba; Song Liu; Tomoko Kanao; Ryosuke Takahashi; Nobutaka Hattori; Yuzuru Imai; Bingwei Lu
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

Review 10.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.